Prevalence of HCV infection at King Chulalongkorn Memorial Hospital.

Authors

  • S. Vandelaer King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
  • N. Hirankarn Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Keywords:

Hepatitis C virus, HCV genotypes, seroprevalence

Abstract

Background : Hepatitis C virus (HCV) infection is a major cause of liver cancer in Thailand. The prevalence of the genotypes of HCV varies according to the geographical location. There is the scarcity of data on the distribution of HCV genotypes in Bangkok.

Objective : The aims of this study were to determine the seroprevalence, genotype distribution from patients of King Chulalongkorn Memorial Hospital, Bangkok.

Methods : This 4-year cross-sectional evaluation of hepatitis C virus infections that involved all patients of King Chulalongkorn Memorial Hospital from January 2012 to December 2015; one thousand two hundred and sixty-two out of 33,911 patients (3.7%) were positive for anti-HCV by CMIA (Chemiluminescent microparticle immunoassay); 544 HCV antibodypositive patients (353 men and 191 women; mean age 52.6 years) were analyzed for HCV-RNA by the COBAS TaqMan HCV test of real time reverse transcription polymerase chain reaction (RT-PCR) and genotyped by the Linear Array HCV Genotyping test (both from Roche).

Results : Six hundred and seventy-two out of 1,262 anti-HCV positive patients (773 men and 489 women; mean age 51.9 years) were analysed for HCV genotype and 544 patients were positive by RT-PCR of the 52' UTR. The core region of the 544 representative patients was sequenced allowing classification into genotype variants 1 (48.5%), 2 (1.1%), 3 (45.4%), 6 (1.5%) and mixed (3.5%).

Conclusion : Hepatitis C seroprevalence rate among patients at King Chulalongkorn Memorial Hospital was 3.7%. The most common genotypes were genotypes 1 and 3. This information might be essential for public health surveillance and prevention of HCV infection.

Downloads

Download data is not yet available.

References

Lauer GM, Walker BD. Hepatitis C Virus Infection. N Engl J Med 2001;345:41-52.

https://doi.org/10.1056/NEJM200107053450107

Louisirirotchanakul S, Puthavathana P, Louisirirotchanakul S, Boonnak K, Lerdsamran H, Tassaneetrithep B. Virology. 2nd eds. Bangkok: Akson Samai Printing House; 2016.

Jarvis LM, Ludlam CA, Simmonds P. Hepatitis C virus genotypes in multi-transfused individuals. Haemophilia 1995;1 Suppl 4:3-7. https://doi.org/10.1111/j.1365-2516.1995.tb00123.x

Modi AA, Liang TJ. Hepatitis C: a clinical review. Oral Dis 2008;14:10-4.

https://doi.org/10.1111/j.1601-0825.2007.01419.x

Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J 2013;14:44.

https://doi.org/10.11604/pamj.2013.14.44.2199

Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y. Hepatitis B and hepatitis C virus in Thai blood donors. Southeast Asian J Trop Med Public Health 2011;42:609-15.

Verachai V, Phutiprawan T, Theamboonlers A, Chinchai T, Tanprasert S, Haagmans BL, et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J Trop Med Public Health 2002;33:849-51.

ธีระ พิรัชวิสุทธิ์. โรคตับอักเสบจากไวรัส ซี. วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต 2546;13:153-66.

Jutavijittum P, Jiviriyawat Y, Yousukh A, Pantip C, Maneekarn N, Toriyama K. Genotypic distribution of hepatitis C virus in voluntary blood donors of northern Thailand. Southeast Asian J Trop Med Public Health 2009;40:471-9.

Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, et al. Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One 2015;10:e0126764.

https://doi.org/10.1371/journal.pone.0126764

Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:47-52. https://doi.org/10.7150/ijms.3.47

World Heahth Organization. Hepatitis C [Internet]. 2017 [cited 2017 Jul 15]. Available from: http://www.who.int/mediacentre/factsheets/ fs164/en/.

Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol 2017;14:122-32. https://doi.org/10.1038/nrgastro.2016.176

Chitapanarux T, Phornphutkul K. Risk Factors for the Development of Hepatocellular Carcinoma in Thailand. J Clin Transl Hepat 2015;3: 182-8. https://doi.org/10.14218/JCTH.2015.000025

Punyagupta S, Jidpugdeebodin S, Siwadune T. Hepatitis C infection and hepatocellular carcinoma in Thailand: a long term study of 63 HCV patients. J Infecti Dis Antimicrob Agents. 1999;16:1-6.

Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV genotyping. Anticancer Res 2007;27:1219-22.

Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016;22:7824-40. https://doi.org/10.3748/wjg.v22.i34.7824

Wasitthankasem R, Posuwan N, Vichaiwattana P, Theamboonlers A, Klinfueng S, Vuthitanachot V, et al. Decreasing hepatitis C virus infection in Thailand in the past decade: Evidence from the 2014 National Survey. PLoS One 2016;11:e0149362. https://doi.org/10.1371/journal.pone.0149362

Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, et al. Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence. PLoS One 2017;12: e0177022. https://doi.org/10.1371/journal.pone.0177022

Suwanagool S, Tieangrim S, Ratanasuwan W, Mekanantagosol S, Luengrojanakul P, Kunasol P. Seroprevalence of anti-HCV among HIV-infected persons and general population. J Med Assoc Thai 1995;78: 611-7.

Mohd HK, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57: 1333-42.

https://doi.org/10.1002/hep.26141

Sunanchaikarn S, Theamboonlers A, Chongsrisawat V, Yoocharoen P, Tharmaphornpilas P, Warinsathien P, et al. Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol 2007;25: 175-82.

Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Poovorawan Y. Seroprevalence and genotype of hepatitis C virus among immigrant workers from Cambodia and Myanmar in Thailand. Intervirology 2011;54:10-6. https://doi.org/10.1159/000318884

Thong VD, Akkarathamrongsin S, Poovorawan K, Tangkijvanich P, Poovorawan Y. Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 2014;20:2927-40. https://doi.org/10.3748/wjg.v20.i11.2927

Centers for Disease Control and Prevention. Viral hepatitis-Hepatitis C information[Internet]. 2015 [cited 2017 Jul 20]. Available from: https://www.cdc.gov/hepatitis/hcv/ guidelinesc.htm.

Downloads

Published

2023-08-15

How to Cite

1.
Vandelaer S, Hirankarn N. Prevalence of HCV infection at King Chulalongkorn Memorial Hospital. Chula Med J [Internet]. 2023 Aug. 15 [cited 2024 Nov. 22];62(1). Available from: https://he05.tci-thaijo.org/index.php/CMJ/article/view/319